Our data showed that anthricin treatment reduced the phosphorylation of Akt, S6K1, and mTOR, suggesting that anthricin inhibits the Akt/mTOR signaling pathway, thus inhibiting breast cancer growth. Here, MTOR is linked to breast carcinoma.